ATS 2024 Final Program

Click on the session title to view the speakers

36

SUNDAY • MAYs 19

1002 Pulmonary Arterial Dysanapsis Evaluated in Smokers With COPD Via Contrast Enhanced Dual Energy CT 1003 Investigating the Contribution of Sex Differences to Small Airways Disease in Chronic Obstructive Pulmonary Disease (COPD) Using Ultra-high Resolution Imaging 1004 Expiratory-inspiratory Ratios of Cross-sectional Lumen Diameter and Longitudinal Length of Spatially Matched Proximal Airway Branches on CT in Patients With COPD 1005 Airway Mucus Plugging in Upper Versus Lower Lobes and Associations With Outcomes in COPD 1006 The Impact of High Ratio of Airway Luminal Volume to Blood Volume in the Lungs on Exacerbations in Chronic Obstructive Pulmonary Disease 1007 CT-based Vascular Surface Area-to-Volume Ratio as an Imaging Marker to Phenotype Subjects With Predominant Vascular Loss Versus Narrowing in COPD 1008 Prevalence of Pulmonary Vascular Abnormalities in Smokers With and Without COPD 1009 Regional Lung Perfusion of Computed Tomography Emphysema Subtypes on Co-registered Computed Tomography and Magnetic Resonance Imaging Scans: The MESA COPD Study Emphysema, A Novel CT Emphysema Subtype, Using Ultra-resolution Micro-CT Imaging 1011 Subtyping Emphysema into Mechanically Impaired Vs. Preserved: Associations With Lung Function, Disease Progression, and Mortality 1012 Proteomics of CT Emphysema Subtypes. The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) 1013 Paired Magnetic Resonance and Computed Tomography Assessment of Dysanapsis. The Subpopulations and Intermediate Outcome Measures in COPD and Heart Failure Study (SPIROMICS HF) 1014 Quantifying the Impact of Cannabis Smoking in Lungs of Young Adults Using CT and 129 Xe MRI 1015 Tracheal Lumen Eccentricity Is Associated With Respiratory Morbidity and Mortality in COPD 1010 Validation of Combined Bronchitic-Apical

1016 Advanced 4D Hyperpolarized Gas Imaging of Ventilation and Dissolved Gas Biomarkers in COPD 1017 Six-month Longitudinal Changes in 129-XE and HRCT Imaging Metrics Tend to Associate With On-study COPD Exacerbations 1018 High Resolution Endotyping of COPD by Evaluating Pulmonary Micro-compartmental Functions With Hyperpolarized 129 Xenon Magnetic Resonance Imaging 1019 Stability and Reproducibility of X-ray Velocimetry for Ventilation Phenotyping in Patients With Chronic Obstructive Pulmonary Disease: A Longitudinal Study (STRIVE-COPD Study) 1020 Effect of Inhaled Triple Therapy on Small Airway Remodelling in Patients With Moderate to Severe COPD Accessed by Endobronchial Optical Coherence Tomography A30 CHALLENGES AS OPPORTUNITIES TO IMPROVE LUNG CANCER DIAGNOSIS AND CARE 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 11A-B (Upper Level) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 501 Nationwide Analysis of Lung Cancer Incidence Spanning Four Decades 502 Comorbid Heart Failure With Preserved Ejection Fraction (HFpEF) and Lung Cancer: Prevalence, Trends, and Impact on Outcomes From the National Inpatient Sample 2016-2020 503 Evaluating the Effect of Telehealth on the Quality of Shared Decision Making Conversations for Lung Cancer Screening 504 Perceived Barriers to Lung Cancer Screening in Asian Americans 505 Non-malignant Resection Rate in Lung Cancer Screening: A Cross-Sectional Analysis 506 The Characteristics of Genetic Variants in LAINS BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

ATS 2024 Conference Program • San Diego, CA